Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1055/a-1146-8674 http://scihub22266oqcxt.onion/10.1055/a-1146-8674 32274773!7295266!32274773     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32274773&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Anasthesiol+Intensivmed+Notfallmed+Schmerzther 2020 ; 55 (4): 257-265 Nephropedia Template TP {{tp|p=32274773|t=2020. SARS-CoV-2/COVID-19: Empfehlungen zu Diagnostik und Therapie |pdf=|usr=}}{{32274773}} gab.com Text SARS-CoV-2/COVID-19: Empfehlungen zu Diagnostik und Therapie JO: Anasthesiol Intensivmed Notfallmed Schmerzther http://www.kidney.de/pget.php?&tw=1&pmid=32274773 #FOAvip COVID-19, a new viral disease affecting primarily the respiratory system and the lung, has caused a pandemic with serious challenges to health systems around the world. In about 20% of patients, severe symptoms occur after a mean incubation period of 5 - 6 days; 5% of patients need intensive care therapy. Morbidity is about 1 - 2%. Protecting health care workers is of paramount importance in order to prevent hospital acquired infections. Therefore, during all procedures associated with aerosol production, a personal safety equipment consisting of a FFP2/FFP3 (N95) respiratory mask, gloves, safety glasses and a waterproof overall should be used. Therapy is based on established recommendations issued for patients with acute lung injury (ARDS). Lung protective ventilation, prone position, restrictive fluid management and an adequate management of organ failures are the mainstays of therapy. In case of fulminant lung failure, veno-venous extracorporeal membrane oxygenation may be used as a rescue in experienced centres. New, experimental therapies evolve with ever increasing frequency; currently, however, there is no evidence based recommendation possible. If off-label and compassionate use of these drugs is considered, an individual benefit-risk assessment is necessary, since serious side effects have been reported. Twit Text FOAVip SARS-CoV-2/COVID-19: Empfehlungen zu Diagnostik und Therapie ????Anasthesiol Intensivmed Notfallmed Schmerzther http://www.kidney.de/pget.php?&tw=1&pmid=32274773 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32274773 #FOAvip English Wikipedia <ref>{{Cite pmid|32274773}}</ref> SARS-CoV-2/COVID-19: Empfehlungen zu Diagnostik und Therapie #MMPMID32274773 Bein B; Bachmann M; Huggett S; Wegermann P Anasthesiol Intensivmed Notfallmed Schmerzther 2020[Apr]; 55 (4): 257-265 PMID32274773show ga COVID-19, a new viral disease affecting primarily the respiratory system and the lung, has caused a pandemic with serious challenges to health systems around the world. In about 20% of patients, severe symptoms occur after a mean incubation period of 5 - 6 days; 5% of patients need intensive care therapy. Morbidity is about 1 - 2%. Protecting health care workers is of paramount importance in order to prevent hospital acquired infections. Therefore, during all procedures associated with aerosol production, a personal safety equipment consisting of a FFP2/FFP3 (N95) respiratory mask, gloves, safety glasses and a waterproof overall should be used. Therapy is based on established recommendations issued for patients with acute lung injury (ARDS). Lung protective ventilation, prone position, restrictive fluid management and an adequate management of organ failures are the mainstays of therapy. In case of fulminant lung failure, veno-venous extracorporeal membrane oxygenation may be used as a rescue in experienced centres. New, experimental therapies evolve with ever increasing frequency; currently, however, there is no evidence based recommendation possible. If off-label and compassionate use of these drugs is considered, an individual benefit-risk assessment is necessary, since serious side effects have been reported. |*Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*diagnosis/*therapy[MESH] |Evidence-Based Medicine[MESH] |Extracorporeal Membrane Oxygenation/*methods[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*diagnosis/*therapy[MESH] |Protective Clothing[MESH] |Respiration, Artificial/methods[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH]SARS-CoV-2/COVID-19: Empfehlungen zu Diagnostik und Therapie (epmc).pdf DeepDyve Pubget Overpricing